Regulation of the human IgE receptor (Fc epsilonRII/CD23) by Epstein-Barr virus (EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23.

An early and critical event in immortalization of human B cells by Epstein-Barr virus (EBV) is induction of CD23 expression. CD23 is constitutively expressed in all EBV-immortalized B cells and its expression is tightly linked with immortalization. We have previously shown that activation of CD23 by EBV occurs at the transcriptional level and is mediated, in part, by EBV-responsive enhancer elements in the region of the type a promoter. We have localized one EBV-responsive enhancer (designated EBVRE) to a 37 bp sequence in intron 1 of type a CD23 that contains a GC-rich sequence that binds nuclear protein(s) from EBV-positive but not EBV-negative cells with sequence specificity. This EBVRE-binding activity was enhanced by protein phosphorylation and did not react with antibodies to the ubiquitous GC box transcription factor, Sp1. We have now shown by protein purification with peptide sequencing and immunological reactivity that p70/p80 Ku autoantigen [the DNA-binding component of DNA-dependent protein kinase (DNA-PK)] binds to this EBVRE with high affinity and sequence specificity. Although Ku autoantigen is ubiquitously expressed, an EBV-specific DNA-protein complex that contains Ku was elicited from EBV-positive but not EBV-negative nuclear extracts. Furthermore, the formation of this EBV-specific DNA-Ku complex was dramatically enhanced by protein phosphorylation. Thus, we have identified EBVRE-binding activity that contains the Ku autoantigen, is DNA sequence specific and is present in EBV-positive but not EBV-negative nuclear extracts. The possible functional significance of the Ku autoantigen-EBVRE interaction is discussed in light of the role of DNA-PK in phosphorylation and activation of several transcription factors. We suggest that phosphorylation of the EBV-specific EBVRE-binding activity by DNA-PK may modulate its activity as a transcription factor.

[1]  Gratien G. Prefontaine,et al.  Sequence-specific DNA binding by Ku autoantigen and its effects on transcription , 1996, Nature.

[2]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[3]  M. Oettinger,et al.  DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect , 1995, Science.

[4]  F. Lottspeich,et al.  Purification of the sequence‐specific transcription factor CTCBF, involved in the control of human collagen IV genes: subunits with homology to Ku antigen. , 1995, The EMBO journal.

[5]  J. Lacy,et al.  Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors. , 1994, Journal of Immunology.

[6]  T. Mimori,et al.  Autoantigen Ku protein is involved in DNA binding proteins which recognize the U5 repressive element of human T‐cell leukemia virus type I long terminal repeat , 1994, FEBS letters.

[7]  F. Alt,et al.  Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. , 1994, Science.

[8]  J. Hsieh,et al.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1 , 1994, Journal of virology.

[9]  E. Kieff,et al.  The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Fienberg,et al.  A DNA-binding activity, TRAC, specific for the TRA element of the transferrin receptor gene copurifies with the Ku autoantigen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Ling,et al.  Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. , 1994, Science.

[12]  J. Blanchard,et al.  Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. , 1994, Cytogenetics and cell genetics.

[13]  A. Yueh,et al.  The carboxyl-terminal transactivation domain of human serum response factor contains DNA-activated protein kinase phosphorylation sites. , 1993, The Journal of biological chemistry.

[14]  T. Curran,et al.  Dimerization and DNA binding alter phosphorylation of Fos and Jun. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Dvir,et al.  Purification and characterization of a template-associated protein kinase that phosphorylates RNA polymerase II. , 1993, The Journal of biological chemistry.

[16]  R. Fotedar,et al.  p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Jackson,et al.  The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.

[18]  H. Lu,et al.  Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Zhang,et al.  On the mechanisms of Ku protein binding to DNA. , 1992, Biochemical and biophysical research communications.

[20]  J. Lacy,et al.  Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1. , 1992, Journal of immunology.

[21]  T. Mimori,et al.  Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA. , 1992, The Journal of biological chemistry.

[22]  C. Anderson,et al.  The nuclear serine/threonine protein kinase DNA-PK. , 1992, Critical reviews in eukaryotic gene expression.

[23]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element , 1991, Journal of virology.

[24]  G. May,et al.  Purification and characterization of Ku-2, an octamer-binding protein related to the autoantigen Ku. , 1991, The Journal of biological chemistry.

[25]  C. Anderson,et al.  Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen , 1990, Molecular and cellular biology.

[26]  N. Thompson,et al.  Purification and characterization of proximal sequence element-binding protein 1, a transcription activating protein related to Ku and TREF that binds the proximal sequence element of the human U1 promoter. , 1990, The Journal of biological chemistry.

[27]  J. Cairns,et al.  Intact, 45‐kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts , 1990, European journal of immunology.

[28]  D. Rio,et al.  Drosophila P element transposase recognizes internal P element DNA sequences , 1989, Cell.

[29]  D. Thorley-Lawson,et al.  B cell activation and the establishment of Epstein-Barr virus latency , 1988, The Journal of experimental medicine.

[30]  Sullivan Jl.  Epstein-Barr virus and lymphoproliferative disorders. , 1988 .

[31]  Carl Wu,et al.  Affinity chromatography of sequence-specific DNA-binding proteins , 1988 .

[32]  J. Sullivan.  Epstein-Barr virus and lymphoproliferative disorders. , 1988, Seminars in hematology.

[33]  I. Dawid,et al.  Purification and properties of Drosophila heat shock activator protein. , 1987, Science.

[34]  J. Banchereau,et al.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Swendeman,et al.  The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.

[36]  K. Welte,et al.  Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells. , 1987, Journal of immunology.

[37]  J. Banchereau,et al.  Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE. , 1987, Journal of immunology.

[38]  R. Hardy,et al.  A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc epsilon R) on lymphocytes. , 1987, Journal of immunology.

[39]  T. Tursz,et al.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Gahmberg,et al.  Identification of a cell‐surface glycoprotein mediating cell adhesion in EBV‐immortalized normal B cells , 1986, International journal of cancer.

[41]  Michael Loran Dustin,et al.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. , 1986, Journal of immunology.

[42]  J A Hardin,et al.  Mechanism of interaction between Ku protein and DNA. , 1986, The Journal of biological chemistry.

[43]  S. Swendeman,et al.  Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens. , 1986, Journal of immunology.

[44]  J. Steitz,et al.  Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. , 1986, The Journal of biological chemistry.

[45]  S. Jalkanen,et al.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man , 1986, European journal of immunology.

[46]  D. Thorley-Lawson,et al.  Early events in Epstein-Barr virus infection provide a model for B cell activation , 1985, The Journal of experimental medicine.

[47]  R. Schooley,et al.  BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. , 1985, Journal of immunology.

[48]  J. Gordon,et al.  Immortalized B lymphocytes produce B-cell growth factor , 1984, Nature.

[49]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[50]  A. German.  M.A. Epstein and B.G. Achong, The Epstein-Barr virus Berlin, Heidelberg, New York (Springer-Verlag ed.) (1979). , 1982 .

[51]  B. Sugden,et al.  Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus , 1981, Nature.

[52]  J. H. Pope.  Transformation by the Virus In Vitro , 1979 .

[53]  H. Hausen,et al.  Establishment of EBNA‐expressing cell lines by infection of Epstein‐Barr virus (EBV)‐genome‐negative human lymphoma cells with different EBV strains , 1976, International journal of cancer.

[54]  A. Goldstein,et al.  Purification and properties , 1975 .

[55]  H. Kikutani,et al.  Epstein-Barr Virus Nuclear Protein 2 Transactivates a cis-Acting CD 23 DNA Element , 2022 .